Unmatched health industry knowledge

Showing 49–60 of 88 projects

• 

  Mapping of the Health Ecosystem & Diabetes and Hypertension Landscape in Central/East Asia

  Unlock essential insights into diabetes and hypertension treatments in Kyrgyzstan, Tajikistan, Papua New Guinea, Cambodia, Laos, and Myanmar. BTHT facilitated one-hour consultations with key opinion leaders, former Ministry of Health members, NGO coordinators, and pharma sector advisors from these regions. These expert discussions provided a comprehensive understanding of local health challenges, trends, and regulations, enabling the consulting firm to develop a well-informed business strategy and navigate the complexities of healthcare delivery in these diverse countries.

  • Central Asia
  • East Asia
  • Kyrgyzstan
  • Tajikistan
  • Papua New Guinea
  • Cambodia
  • Laos
  • Myanmar
  • Pharma
• 

  Medical Telemonitoring Trends for Hypertension, Diabetes, Chronic Kidney Diseases in France

  Deep dive in the medical telemonitoring market for hypertension, diabetes and chronic kidney diseases in Brazil. Gain a comprehensive understanding of the challenges surrounding regulations and discover strategic opportunities.

  • Europe
  • France
  • Healthcare IT
• 

  DNA Ancestry Tests Regulatory Challenges and Market Opportunities in Brazil

  Uncover important insights about the DNA ancestry test market and navigate the regulatory complexities in Brazil. Gain a comprehensive understanding of the challenges surrounding regulations and discover strategic opportunities in the field of genetic testing. Explore further!

  • LATAM
  • Brazil
  • Medtech
• 

  Market Access Pricing and Reimbursement in Europe for an In-Vitro Diagnostic (IVD) Test

  Unlock the secrets to successful market access for IVD tests across Europe. BTHT’s team connected the client with former payors and market access specialists to dissect the complexities of pricing, reimbursement, and regulatory challenges. Our expert calls provided in-depth insights into diverse European healthcare systems, revealing key strategies for market entry and optimization. This thorough analysis equipped the pharmaceutical company with a strategic blueprint, essential for navigating the European market and enhancing their IVD test’s market access strategy.

  • Europe
  • Germany
  • Italy
  • France
  • UK
  • Spain
  • Diagnostics
• 

  Global Purchasing Trends of Generic Active Pharmaceutical Ingredients (APIs)

  Uncover the prevailing procurement and supply chain trends of Generic Active Pharmaceutical Ingredients (APIs) on a global scale. Gain valuable insights into market dynamics, supplier networks, sourcing strategies, and cost considerations. Stay ahead in the pharmaceutical industry's procurement landscape with essential data to optimize your supply chain and drive strategic decision-making.

  • Global
  • US
  • Europe
  • Italy
  • UK
  • Spain
  • France
  • Germany
  • Asia
  • Pharma
  • CDMO
• 

  Global Generic Active Pharmaceutical Ingredients (APIs) Market Trends and Opportunities

  Discover valuable perspectives on the Global Generic Active Pharmaceutical Ingredients (APIs) Market, encompassing the current trends, opportunities, and drivers in this area.

  • Global
  • US
  • Europe
  • Italy
  • UK
  • Spain
  • France
  • Germany
  • Asia
  • Pharma
  • CDMO
• 

  Patient and Insurance Pathways for Hearing Loss Cell and Gene Therapies in the US

  Delve into the pathways for hearing loss cell and gene therapies in the US, examining doctor experiences and insurance coverages.

  • North America
  • US
  • Pharma
  • Biotech
• 

  Global Assay Systems and Affinity Technologies Usage in Academia, Biotech and CROs

  Explore the landscape of affinity technologies in drug discovery. BTHT's experts with expertise in systems like HIPStA and CETSA, and provided insights from market experts on trends, key players, and purchasing criteria. Discover how these technologies are shaping drug research and development.

  • Global
  • US
  • Europe
  • Italy
  • UK
  • Spain
  • France
  • Germany
  • Pharma
  • Biopharma
  • Biotech
  • CRO
  • Medtech
• 

  Market Dynamics and Pricing Positioning for Specific Synthetic Products and Small Molecules Active Pharmaceutical Ingredients (APIs)

  Discover the latest trends in synthetic products and small molecule APIs. BTHT's experts engaged with the client to explore market dynamics and pricing strategies, focusing on the competitive landscape and key factors influencing API pricing. Insights from former CDMO executives and BU Managers highlighted strategies for optimizing market positioning and navigating pricing challenges, offering actionable guidance to enhance investment decisions and strategic planning in the API sector.

  • Global
  • US
  • Europe
  • Italy
  • UK
  • Spain
  • France
  • Germany
  • Asia
  • Pharma
  • Biopharma
  • CDMO
  • Biotech
• 

  Regulatory Trends and Public Affairs in Radiology and Medical Imaging in France

  Explore the evolving regulatory landscape in radiology and medical imaging in France. BTHT's experts connected with the client to delve into the latest regulatory trends and public affairs impacts. Engaging with Public Affairs Specialists and Key Opinion Leaders (KOLs), our discussions uncovered crucial insights into policy shifts and strategic factors shaping the industry. This comprehensive analysis provided the private equity client with the strategic clarity needed to navigate regulatory challenges and make informed investment decisions.

  • Europe
  • France
  • Medtech
• 

  Real World Evidence (RWE) Providers Market for Pharmaceutical Companies in Europe and in the US

  Gain insights into the Real World Evidence (RWE) market for drug development. BTHT's experts helped the client explore the need for RWE, market size, growth drivers, and the choice between in-house and third-party services.

  • Global
  • Europe
  • US
  • Pharma
  • Biopharma
  • Biotech
• 

  Vaccine Market Outlook, Key Trends and Product Pipeline and in the US

  Explore the US private-pay vaccine market with insights into vaccination trends, consumer behavior, and emerging vaccines. BTHT's experts provided comprehensive overview of market dynamics and future opportunities for non-COVID vaccines.

  • US
  • Pharma
  • Biopharma
  • Biotech